| Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration JM McFarland, ZV Ho, G Kugener, JM Dempster, PG Montgomery, ... Nature communications 9 (1), 4610, 2018 | 328 | 2018 |
| Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence Z Wu, J Zhou, X Zhang, Z Zhang, Y Xie, J Liu, ZV Ho, A Panda, X Qiu, ... Nature Genetics 53 (6), 881-894, 2021 | 46 | 2021 |
| Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers C Price, S Gill, ZV Ho, SM Davidson, E Merkel, JM McFarland, L Leung, ... Cancer research 79 (10), 2564-2579, 2019 | 34 | 2019 |
| Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration. Nat Commun. 2018; 9 (1): 4610 JM McFarland, ZV Ho, G Kugener, JM Dempster, PG Montgomery, ... Epub 2018/11/06. https://doi. org/10.1038/s41467-018-06916-5 PubMed Central …, 0 | 19 | |
| Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration. Nat. Commun. 9, 4610 JM McFarland, ZV Ho, G Kugener, JM Dempster, PG Montgomery, ... | 8 | 2018 |
| Developing SHP2-based combination therapy for KRAS-amplified cancer T Li, O Kikuchi, J Zhou, Y Wang, B Pokharel, K Bastl, P Gokhale, A Knott, ... JCI insight 8 (3), 2023 | 3 | 2023 |
| Developing combination therapy with SHP2 inhibition for CIN-type gastroesophageal adenocarcinoma with KRAS amplification O Kikuchi, T Li, J Zhou, Y Wang, K Bastl, PC Gokhale, A Knott, Y Zhang, ... Cancer Research 82 (12_Supplement), 6377-6377, 2022 | | 2022 |
| Understanding HIF1A-mediated therapy in clear cell ovarian cancer. C Price, S Gill, ZV Ho, SM Davidson, E Merkel, JM McFarland, L Leung, ... CLINICAL CANCER RESEARCH 26 (13), 73-73, 2020 | | 2020 |
| Abstract A67: Understanding HIF1A-mediated therapy in clear cell ovarian cancer C Price, S Gill, ZV Ho, SM Davidson, E Merkel, JM McFarland, L Leung, ... Clinical Cancer Research 26 (13_Supplement), A67-A67, 2020 | | 2020 |
